Mood disorders and the reproductive cycle: Affective disorders during the menopause and premenstrual dysphoric disorder

Psychopharmacology Bulletin

Volumn 34, Issue 3, 1998, Pages 313-318

  Haynes, Patricia ^a   Parry, Barbara L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Depression; Menopause; Premenstrua; Reproductive cycle; Women

Indexed keywords

ANTIDEPRESSANT AGENT; CONJUGATED ESTROGEN; GONADORELIN AGONIST; MEDROXYPROGESTERONE ACETATE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFECTIVE NEUROSIS; CONFERENCE PAPER; DEPRESSION; DYSPHORIA; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; MENTAL DISEASE; MOOD; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REPRODUCTION;

FEMALE; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; MOOD DISORDERS; PREMENSTRUAL SYNDROME; REPRODUCTION;

EID: 0031791628     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. American Psychiatric Association. DSM-II: Diagnostic and Statistical Manual of Mental Disorders. 2nd ed. Washington, DC: The Association, 1968.
2. American Psychiatric Association. DSM-III: Diagnostic and Statistical Manual of Mental Disorders. 3d ed. Washington, DC: The Association, 1980.
3. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3d ed., revised. Washington, DC: The Association, 1987.
4. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: APA, 1994.
5. Angst, J. The course of affective disorders. II. Typology of bipolar manic-depressive illness. Arch. Psychiatr. Nervankr. 226:65-72, 1978.
6. Avis, NE; Brambilla, D; McKinlay, SM; and Vass, K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann. Epidemiol. 4:214-220, 1994.
7. Ballinger, CB. Psychiatric morbidity and the menopause. Screening of General Population Sample. Br. Med. J. 9:344-346, 1975.
8. Bebbington, P; Hurry, J; Tennant, C; Sturt, E; and Wing, JK. Epidemiology of mental disorders in Camberwell. Psychol. Med. 11:561-579, 1981.
9. Beck, AT; Ward, CH; Mendelson, M; Mock, J; and Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatry 4:561-571, 1961.
10. Blatt, MG; Wiesbader, H; and Kupperman, HS. Vitamin E and the climacteric syndrome. Arch. Intern. Med. 91:792-799, 1953.
11. Eagles, JM, and Whalley, LJ. Aging and affective disorders: The age at first onset of affective disorders in Scotland, 1969-1978. Br. J. Psychiatry 147:180-187, 1985.
12. First, MB; Spitzer, RL; Gibbon, M; and Williams, JBW. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
13. Halbreich, U, and Endicott, J. Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr. Scand. 71:331-338, 1985.
14. Halbreich, U; Endicott, J; and Nee, J. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr. Scand. 65:46-65, 1982.
15. Halbreich, U; Rojansky, N; Palter, S; Tworek, H; Hissin, P; and Wang, K. Estrogen augments serotonergic activity in postmenopausal women. Biol. Psychiatry 37:434-441, 1995.
16. Hamilton, JA; Parry, BL; Alagna, S; Blumenthal, S; and Herz, E. Premenstrual mood changes: A guide to evaluation and treatment. Psychiatr. Ann. 14:426-435, 1984.
17. Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:278-296, 1967.
18. Hargrove, JT, and Eisenberg, E. Menopause. Med. Clin. North Am. 79:1337-1356, 1995.
19. Kaufert, PA; Gilbert, P; and Hassard, T. Researching the symptoms of menopause: An exercise in methodology. Maturitas 10:117-131, 1988.
20. Kendall, DA; Stancel, AM; and Enna, SJ. Imipramine: Effect of ovarian steroids on modifications in serotonin receptor binding. Science 211:1183, 1981.
21. Klaiber, EL; Broverman, DM; Vogel, W; and Kobayashi, Y. Estrogen therapy for severe persistent depressions in women. Arch. Gen. Psychiatry 36:550-554, 1979.
22. Korzekwa, MI; Lamont, JA; and Steiner, M. Late luteal phase dysphoric disorder and the thyroid axis revisited. J. Clin. Endocrinol. Metab. 81:2280-2284, 1996.
23. Kronenberg, F. Hot flashes: Phenomenology, quality of life, and search for treatment options. Exp. Gerontol. 29:319-36, 1994.
24. Logue, C, and Moos, R. Perimenstrual symptoms: Prevalence and risk factors. Psychosom. Med. 48:388-414, 1986.
25. Magos, AL; Brewster, E; Singh, R; O'Dowd, T; Brincot, M; and Stull, JWW. The effects of norethisterone in postmenopausal women on estrogen replacement therapy. A model for the premenstrual syndrome. Br. J. Obstet. Gynecol. 93:1290-1296, 1986.
26. Moos, RH. The development of a menstrual distress questionnaire. Psychosom. Med. 30:853-867, 1968.
27. Mortola, JF; Girton, L; Beck, L; and Yen, SSC. Diagnosis of premenstrual syndrome by a single and reliable instrument. The calendar of premenstrual experiences. Obstet. Gynecol. 76:302-307, 1990.
28. Mortola, JF; Girton, L; and Fisher, U. Successful treatment of severe premenstrual syndrome by combined use of GnRH agonist and estrogen/progestin. J. Clin. Endocrinol. Metab. 72:252A-252F, 1991.
29. Neugarten, BL, and Kraines, RJ. Menopausal symptoms in women of various ages. Psychosom. Med. 27:266-273, 1965.
30. Oppenheim, G. A case of rapid mood cycling with estrogen: Implications for therapy. J. Clin. Psychiatry 45:34-35, 1984.
31. Parry, BL; Hauger, R; Lin, E; LeVeau, B; Mostofi, N; Clopton, PL; and Gillin, JC. Neuroendocrine effects of light therapy in late luteal phase dysphoric disorder. Biol. Psychiatry 36:356-364, 1994.
32. Parry, BL, and Rausch, JL. Evaluation of biologic research. In: Gise, LH, eds. Contemporary Issues in Obstetrics and Gynecology, Vol. 2. (Kase, NG, and Berkowitz, RL, ser eds.) New York: Churchill Livingston, 1988.
33. Parry, BL; Rosenthal, NE; and Wehr, TA. Research techniques used to study premenstrual syndrome. In: Osofsky, HJ, and Blumenthal, SJ, eds. Premenstrual Syndrome: Current Findings and Future Directions. Washington, DC: American Psychiatric Association, 1985.
34. Rabin, DS; Schmidt, PJ; Campbell, G; Gold, PW; Jensvold, M; Rubinow, DR; and Chrousos, GP. Hypothalamic-pituitary-adrenal function in patients with premenstrual syndrome. J. Clin. Endocrinol. Metab. 71:1158-1162, 1990.
35. Radloff, L. The CES-D scale: A self-report depression scale for research in general population. Appl. Psychol. Meas. 1:385-401, 1977.
36. Rapkin, AJ. The role of serotonin in premenstrual syndrome. Clin. Obstet. Gynecol. 35:629-636, 1992.
37. Rosenthal, SH. The involutional depressive syndrome. Am. J. Psychiatry 124(Suppl):21-35, 1968.
38. Schatzberg, A. "HPA axis interventions as treatment of depression." Presented at the International Society for Psychoneuroendocrinology, San Francisco, CA, July 1997.
39. Schmidt, PJ; Nieman, LK; Grover, GN; Muller, KL; Merriam, GR; and Rubinow, DR. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N. Engl. J. Med. 324:1174-1179, 1991.
40. Schneider, LS; Small, GW; Hamilton, SH; Bystritsky, A; Nemeroff, CB; Meyers, BS; and the Fluoxetine Collaborative Study Group. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am. J. Geriat. Psychiatry 5:97-106, 1997.
41. Shapira, B; Oppenheim, G; Zohar, J; Segal, M; Malach, D; and Belmaker, R. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol. Psychiatry 20:570-583, 1985.
42. Sherwin, BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J. Clin. Endocrinol. Metab. 72:336-343, 1991.
43. Sherwin, BB, and Gelfand, MM. A prospective one-year study of estrogen and progestin in postmenopausal women. Effects on clinical symptoms and lipoprotein lipids. Obstet. Gynecol. 73:759-766, 1989.
44. Stahl, S. "Role of hormone therapies for refractory depression." Presented at the American Psychiatric Association Meeting, New York, NY, May 1996.
45. Steiner, M; Haskett, RF; and Carroll, BJ. Premenstrual tension syndrome. The development of research diagnostic criteria and new rating scales. Acta Psychiatr. Scand. 62:177-190, 1980.
46. Steiner, M; Steinberg, S; Stewart, D; Carter, D; Berger, C; Reid, R; Grover, G; and Streiner, D (for the Canadian Fluoxetine/ Premenstrual Dysphoria Collaborative Study Group). Fluoxetine in the treatment of premenstrual dysphoria. N. Engl. J. Med. 332:1529-1534, 1995.
47. Stewart, DE, and Boydell, KM. Psychologic distress during menopause: Associations across the reproductive life cycle. Intl. Psychiatry in Medicine 23:157-162, 1993.
48. Tam, LW, and Parry, BL. New findings in the treatment of depression at menopause. Submitted for publication, 1997.
49. Thomas, EM, and Armstrong, SM. Effect of ovariectomy and estradiol on unity of female rat circadian rhythms. Am. J. Physiol. 257:R1241-R1250, 1989.
50. Walker, A. Theory and methodology in premenstrual syndrome research. Social Science and Medicine 41:793-800, 1995.
51. Weissman, MW. "Epidemiology of major depression in women. Women and the controversies in hormonal replacement therapy." Presented at the American Psychiatric Association Meeting, New York, NY, May 1996.
52. Williams, JBW; Link, MJ; Rosenthal, NE; Amira, L; and Terman, M. Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH-SAD), revised edition. New York: New York State Psychiatric Institute, 1994.
53. Wise, PM; Krajnak, KM; and Kashon, ML. Menopause. The aging of multiple pacemakers. Science 273:67-70, 1996.
54. Woods, NF, and Mitchell, ES. Patterns of depressed mood in midlife women. Observation from the Seattle Midlife Women's Health Study. Res. Nurs. Health 19:111-123, 1996.
55. Woods, NF; Most, A; and Dery, GK. Prevalence of perimenstrual symptoms. Am. J. Pub. Health 72(11):1257-1264, 1982.
56. Yonkers, KA; Halbreich, U; Freeman, E; Brown, C; Endicott, J; Frank, E; Parry, B; Pearlstein, T; Severino, S; Stout, A; Stone, A; and Harrison, W (for the Sertraline Premenstrual Dysphoric Collaborative Study Group.) Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial. JAMA 278(12):983-988, 1997.